1. Home
  2. TPCS vs LSTA Comparison

TPCS vs LSTA Comparison

Compare TPCS & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TPCS
  • LSTA
  • Stock Information
  • Founded
  • TPCS 1956
  • LSTA 1980
  • Country
  • TPCS United States
  • LSTA United States
  • Employees
  • TPCS N/A
  • LSTA N/A
  • Industry
  • TPCS Metal Fabrications
  • LSTA Misc Health and Biotechnology Services
  • Sector
  • TPCS Industrials
  • LSTA Health Care
  • Exchange
  • TPCS Nasdaq
  • LSTA Nasdaq
  • Market Cap
  • TPCS 44.9M
  • LSTA 20.9M
  • IPO Year
  • TPCS N/A
  • LSTA N/A
  • Fundamental
  • Price
  • TPCS $4.99
  • LSTA $2.79
  • Analyst Decision
  • TPCS
  • LSTA Strong Buy
  • Analyst Count
  • TPCS 0
  • LSTA 2
  • Target Price
  • TPCS N/A
  • LSTA $23.50
  • AVG Volume (30 Days)
  • TPCS 31.6K
  • LSTA 48.8K
  • Earning Date
  • TPCS 08-21-2025
  • LSTA 11-06-2025
  • Dividend Yield
  • TPCS N/A
  • LSTA N/A
  • EPS Growth
  • TPCS N/A
  • LSTA N/A
  • EPS
  • TPCS N/A
  • LSTA N/A
  • Revenue
  • TPCS $33,424,000.00
  • LSTA $1,070,000.00
  • Revenue This Year
  • TPCS N/A
  • LSTA N/A
  • Revenue Next Year
  • TPCS N/A
  • LSTA N/A
  • P/E Ratio
  • TPCS N/A
  • LSTA N/A
  • Revenue Growth
  • TPCS 3.78
  • LSTA N/A
  • 52 Week Low
  • TPCS $2.05
  • LSTA $1.87
  • 52 Week High
  • TPCS $6.25
  • LSTA $4.20
  • Technical
  • Relative Strength Index (RSI)
  • TPCS 42.51
  • LSTA 50.42
  • Support Level
  • TPCS $4.60
  • LSTA $2.43
  • Resistance Level
  • TPCS $5.23
  • LSTA $2.79
  • Average True Range (ATR)
  • TPCS 0.33
  • LSTA 0.16
  • MACD
  • TPCS -0.06
  • LSTA 0.02
  • Stochastic Oscillator
  • TPCS 20.99
  • LSTA 47.27

About TPCS TechPrecision Corporation Common stock

Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components. It derives maximum revenue from Ranor segment.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.

Share on Social Networks: